Core Insights - A research team from Mie University and other institutions in Japan has successfully utilized gene editing technology to remove the extra 21st chromosome from cells of patients with Down syndrome, confirming the results in a publication in the Proceedings of the National Academy of Sciences [1][2] Group 1: Research Methodology - The team extracted fibroblasts from the skin of Down syndrome patients to cultivate induced pluripotent stem cells (iPS cells) [2] - They developed three types of iPS cells, each with one of the three 21st chromosomes deleted, and constructed a CRISPR/Cas9 system to target and cut the extra chromosome at multiple sites [2] - The CRISPR/Cas9 system achieved a removal accuracy of up to 37.5% for the target 21st chromosome [2] Group 2: Findings and Implications - Analysis of the modified iPS cells showed that their characteristics, including gene expression patterns, cell proliferation rates, and reactive oxygen handling, had returned to normal [2] - The CRISPR/Cas9 system was also confirmed to be effective in removing chromosomes from differentiated cells, such as fibroblasts and non-dividing cells [2] Group 3: Future Directions - The technology is currently in the concept validation stage through in vitro cell experiments and has some limitations [2] - Future research will focus on developing safer chromosome removal techniques that do not rely on cutting [2]

Core Viewpoint - The Chinese government criticizes the U.S. for imposing sanctions on Chinese companies and urges the U.S. to correct its actions, emphasizing the need to protect the legitimate rights of Chinese enterprises [1] Group 1: U.S. Sanctions on Chinese Entities - The U.S. Department of Commerce has added multiple Chinese entities to its export control "entity list" as of September 12, 2025 [1] - The Chinese government views the U.S. actions as an abuse of export controls under the guise of national security, affecting sectors such as semiconductors, biotechnology, aerospace, and logistics [1] Group 2: Impact on Global Trade - The Chinese government argues that U.S. unilateral actions disrupt normal business exchanges between countries, distort the global market, and harm the legitimate rights of enterprises [1] - The sanctions are seen as detrimental to the stability and security of global supply chains and industrial chains [1]

Group 1 - The core viewpoint of the articles highlights the ongoing tensions between the US and China regarding trade and export controls, particularly focusing on the recent sanctions imposed by the US on several Chinese entities [1][2] - The Chinese Ministry of Commerce has expressed strong opposition to the US's unilateral actions, claiming they distort the global market and harm legitimate business interests [1] - The upcoming US-China economic talks in Spain, scheduled for September 14-17, will address issues such as unilateral tariffs, export control abuses, and the TikTok situation [1][2] Group 2 - The Chinese government maintains a firm stance on protecting the rights of its companies, particularly regarding the TikTok issue, emphasizing its commitment to data privacy and security [2] - The Chinese side urges the US to engage in dialogue based on mutual respect and equality to resolve concerns and create a fair business environment for Chinese companies operating in the US [2]

Core Viewpoint - The article discusses China's strong opposition to the U.S. Department of Commerce's decision to place multiple Chinese entities on the export control "Entity List," highlighting concerns over unilateralism and the impact on global trade and supply chains [2]. Group 1: U.S. Export Controls - The U.S. has generalized national security concerns and abused export controls against several Chinese entities in sectors such as semiconductors, biotechnology, aerospace, and logistics [2]. - The U.S. actions are seen as a means to prioritize its own interests over the development rights of other countries, particularly China [2]. Group 2: Impact on Global Trade - The sanctions are viewed as damaging to normal business exchanges between countries, distorting the global market and harming the legitimate rights of enterprises [2]. - The measures threaten the safety and stability of global supply chains and industrial chains [2]. Group 3: Response and Future Actions - China urges the U.S. to correct its actions and cease the unreasonable suppression of Chinese enterprises [2]. - China plans to take necessary measures to firmly protect the legitimate rights of its companies [2].

Group 1 - Zhengzhou Shihui Biotechnology Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The legal representative of the company is He Jianfei [1] - The company's business scope includes technology services, sales of daily masks (non-medical), and various other daily necessities [1] Group 2 - The company is involved in the wholesale and retail of personal hygiene products, cosmetics, and medical devices [1] - The company is permitted to operate independently within the scope of its business license, excluding projects that require approval [1]

Group 1 - The company Shanghai Youningwei Biotechnology Co., Ltd. will participate in the 2025 Shanghai Listed Companies Collective Reception Day and Mid-Year Performance Briefing [1][2] - The event will be held online on September 19, 2025, from 15:00 to 17:00, allowing investors to engage with the company's management [2] - Key company representatives, including the chairman and general manager, independent directors, and the financial director, will address investor concerns regarding the company's half-year performance, governance, and strategic development [2] Group 2 - Investors can submit questions for discussion until 14:00 on September 19, 2025, through a designated webpage [2] - The company aims to enhance communication with investors and ensure that the discussion is relevant to their interests [2][3]

Group 1 - The sixth China Liaoning International Investment and Trade Fair (Liaoning Fair) will be held from September 25 to 28 in Shenyang, with the theme "New Era of Northeast Revitalization, New Journey of Win-Win Cooperation" [1] - This year's fair features three main characteristics: highlighting Northeast Asia elements, offering a richer array of activities, and attracting higher attention [1] - The event will include over 100 activities, with participation from dignitaries and envoys from more than 50 countries, as well as representatives from "World 500" and "Private 500" companies [1] Group 2 - The opening ceremony on September 25 will be a key event, attended by nearly 700 representatives from "World 500" companies, state-owned enterprises, private enterprises, and business associations [2] - A total of 181 key projects are expected to be signed during the fair, showcasing the achievements of the province's revitalization efforts [2] - The fair will host four "Invest in Liaoning" international economic and trade matching activities, and several bilateral cooperation events with Japan, Mongolia, and Uzbekistan [2] Group 3 - A series of supporting activities will include sharing sessions on new productivity themes, featuring speakers from China Export & Credit Insurance Corporation and BGI Group [3] - A total of 46 economic and trade investment-related supporting activities and 63 cultural tourism brand activities will be organized by various cities during the fair [3] - The theme exhibition will showcase the results of the comprehensive revitalization efforts, including various specialized pavilions [3] Group 4 - The second Liaoning Business Conference and the 2025 Pujiang Innovation Forum Liaoning Sub-Forum will be significant components of this year's fair [4] - The Liaoning Business Conference will attract over 600 representatives from Liaoning businesses across 28 provinces and nearly 40 countries [4] - The 2025 Shenyang-Korea Investment and Trade Expo will coincide with the Liaoning Fair, featuring activities aimed at promoting local industries such as esports and cultural entertainment [4]

Core Insights - The Chinese government is enhancing the overseas comprehensive service system to support enterprises in international cooperation and competition [1][5][6] - There is a growing demand for high-quality overseas comprehensive services as Chinese companies increasingly seek to expand internationally [3][4][5] Group 1: Government Initiatives - The State Council is focusing on improving the overseas comprehensive service system, integrating resources in legal, financial, and logistics services [1][6] - The government aims to establish overseas service stations in key countries and support local areas in creating comprehensive service ports for outbound enterprises [1][6][7] Group 2: Investment and Trade Statistics - China's foreign direct investment (FDI) stock has reached $3.1 trillion, maintaining a top-three global position for eight consecutive years [3] - In 2024, China's FDI flow is projected to be $192.2 billion, an 8.4% increase from the previous year, representing 11.9% of global investment flow [3] Group 3: Business Environment - The global economic recovery is challenging, with increasing competition and trade barriers, leading to a heightened need for quality overseas services [5] - Chinese enterprises are actively pursuing internationalization, particularly in sectors like semiconductors, automotive, renewable energy, and biotechnology [4]

Group 1: QDII Fund Overview - As of September 12, the total number of QDII funds reached 314, with a total scale of 673 billion yuan, an increase of 141 billion yuan from the beginning of the year, representing a growth rate of 26.5% [1] - Among these, there are 215 equity QDII funds with a scale of 567.7 billion yuan, which accounts for the highest proportion in terms of both number and scale [1] - The significant growth in QDII fund scale this year reflects an increased demand for global asset allocation and improved risk tolerance among investors, influenced by the performance of certain QDII funds [1] Group 2: Performance of QDII Funds - The Hong Kong stock market has performed well this year, contributing to the strong performance of several QDII funds, with 25 funds showing a net value growth rate exceeding 80%, and some surpassing 100% [1] - Thematic funds focusing on innovative drugs and biotechnology have shown particularly strong performance [1] - Market experts attribute the strong performance of QDII funds to ample liquidity in the Hong Kong market and a robust valuation recovery, especially in sectors like innovative drugs, consumption, and technology [1] Group 3: Biopharmaceutical Industry Insights - The biopharmaceutical sector, including gene editing and synthetic biology, is recognized as a key driver for the development of new productive forces in China and is crucial for building a healthy China [2] - The long-term development of the biopharmaceutical industry is fundamentally driven by rigid demand, making it an attractive investment area for many investors [2] - Recent favorable policies in the domestic pharmaceutical industry support the development of innovative drugs across the entire chain, accelerating industry transformation [2]

南非比勒陀利亚大学研发出新型皮肤替代产品 中新网约翰内斯堡9月12日电 南非广播公司12日报道称，南非比勒陀利亚大学新研发出一种新型皮肤替 代产品"无细胞真皮支架(ADS)"，为未来3D生物打印天然皮肤铺平道路，成为传统皮肤移植的替代方 案。 该研究负责人哈菲扎·帕卡尔(Doctor Hafiza Parkar)介绍，无细胞真皮支架是一种用于严重创口的皮肤替 代产品，能够模拟人体皮肤，在动物实验中已显示出加速愈合的效果。 帕卡尔说，它的作用是为机体提供一个框架，以便长出新的健康组织。动物实验显示，它能减少移植中 常见的排斥反应，同时加快愈合速度，对于烧伤、溃疡等复杂创面尤其有效。(完) 来源：中国新闻网 编辑：陈俊明 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 ...